Evidence map›Paper›PMID 36845980›Full record

ArticleDrug and alcohol dependence reports2022

Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection.

Adam Viera, Lauretta E Grau, Jeffrey D Fisher, Scott O Farnum, Jeanette M Tetrault, Greg Scott, Robert Heimer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug and alcohol dependence reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Adam VieraDepartment of Social and Behavioral Sciences, Yale University School of Public Health, New Haven, CT, USA.
Lauretta E GrauDepartment of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA.
Jeffrey D FisherDepartment of Psychological Sciences and the Institute for Collaboration on Health, Intervention, and Policy (InCHIP), University of Connecticut, Storrs, CT USA.
Scott O FarnumAPT Foundation, Inc, New Haven, CT USA.
Jeanette M TetraultDepartment of Internal Medicine and the Yale Addiction Medicine Program, Yale University School of Public Health, New Haven, CT, USA.
Greg ScottDepartment of Sociology, DePaul University, Chicago, IL USA.
Robert HeimerDepartment of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA.
Yale University · USAPT Foundation · USDePaul University · USUniversity of Connecticut · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

•We developed a two-session behavioral intervention to prevent HCV reinfection.•The intervention was piloted at an OTP and integrated into HCV treatment.•Baseline data showed limited knowledge & application of safer injection practices.•Implementation barriers included logistics and the lack of financial incentive.•Adaptations addressed barriers, yielding a more feasible and acceptable intervention.

Identifiers

PMID36845980
PMCPMC9948939
OpenAlexW4226474278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.